Concord Drugs Share Price History and Returns 2015 to 2024
Concord Drugs Limited | |||
 | Symbol: CONCORD | ||
| Price: ₹35.74 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Concord Drugs Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Concord Drugs Recent Performance
- 3: Concord Drugs Stock Price Chart From 2015 to 2024
- 4: Concord Drugs Stock Price History Table From 2015 to 2024
- 5: Analyzing the Impact of Investing in Concord Drugs
- 5.1: Concord Drugs Stock Returns In Last 5 Years
- 5.2: Concord Drugs Stock VS FD (Normal) VS FD (Compounding)
Concord Drugs Stock Highlights
As of Thu 21 Nov 2024, Concord Drugs Stock price is ₹35.74 which is ₹25.76 below 52-week high of ₹61.5 and ₹5.15 above 52-week low of ₹30.59
52-Week High Low
- Concord Drugs 52-Week High is ₹61.5 occured on Fri 29 Dec 2023
- Concord Drugs 52-Week Low is ₹30.59 occured on Tue 13 Aug 2024
All Time High
- The all-time high or the highest price that Concord Drugs stocks have ever touched was ₹91.25 and this occurred on Wed 01 Apr 2015.
- The highest closing price at which Concord Drugs stocks have ever closed was ₹78.95 recorded on Sun 01 Mar 2015.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Concord Drugs Recent Performance
Over the past 21 trading days, the value of Concord Drugs's stock has decreased by ₹1.76 (-4.69%). On 17 Oct 2024, its one share was worth ₹37.50 and by 21 Nov 2024, the value dropped to ₹35.74. During this period it created a highest high of ₹40.99 and lowest low of ₹33.00.
Below Image represents line chart of daily close price of Concord Drugs, helping you visualize how the price has changed day by day.
Concord Drugs Stock Price Chart From 2015 to 2024
Concord Drugs Stock Price History Table From 2015 to 2024
| Year | Concord Drugs | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2015 | ₹59.55 | - | ↑ ₹91.25 ↓ ₹25.45 |
| 2016 | ₹49.00 | -17.8% | ↑ ₹79.45 ↓ ₹42.25 |
| 2017 | ₹32.00 | -34.7% | ↑ ₹73.00 ↓ ₹26.25 |
| 2018 | ₹22.60 | -29.4% | ↑ ₹35.80 ↓ ₹15.05 |
| 2019 | ₹15.00 | -33.7% | ↑ ₹24.30 ↓ ₹12.35 |
| 2020 | ₹22.90 | 52.6% | ↑ ₹32.80 ↓ ₹11.68 |
| 2021 | ₹32.15 | 40.3% | ↑ ₹44.95 ↓ ₹20.85 |
| 2022 | ₹32.55 | 1.2% | ↑ ₹41.65 ↓ ₹19.50 |
| 2023 | ₹59.72 | 83.4% | ↑ ₹61.50 ↓ ₹24.80 |
| 2024 | ₹35.74 | -40.2% | ↑ ₹38.95 ↓ ₹35.02 |
Analyzing the Impact of Investing in Concord Drugs
Concord Drugs Stock price in the year 2015 was ₹59.55. If you had invested ₹10,000 in Concord Drugs Stock in 2015, in 9 years, your investment would have reduced to ₹6,001 by the end of 2024. This represents a negative return of -400.00% from 2015 to 2024, with a compound annual growth rate (CAGR) of -5.6%.
Concord Drugs Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: 61.50 and lowest was: 11.68
- Concord Drugs Stock price in 2019 was 15.00
- By 2024, its stock price rose to 35.74
- It gave a positive return of over 138% with a CAGR of 18.9% over the last 5 years
- If you had invested 10,000 in Concord Drugs in 2019 then in 5 years, your investment would have grown to 23,826 by 2024, which is 2.38 times of your initial investment.
Concord Drugs Stock VS FD (Normal) VS FD (Compounding)
You might wonder which option is better: Concord Drugs stocks, fixed deposits (FDs) or compounding FDs. Let’s compare them and see how they differ.To help you make a well-informed decision, we have prepared a handy table that compares the returns of Concord Drugs Stock with both FD choices over time.
If you invested ₹10,000 each in these 3 options in null:
| Year | Concord Drugs Investment | FD Normal Investment | FD Compond Investment |
|---|---|---|---|
| 2015 | ₹10,000 | ₹10,000 | ₹10,000 |
Then today, your investment would have become this much in each option: | |||
| 2024 | ₹5,970.30 | ₹15,400.00 | ₹16,894.79 |
Note: The Stock price data displayed on this web page has been adjusted for any bonus Stocks or Stock splits that occurred over time.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
